Bio

Accomplished manager with >25 years experience in the Pharmaceutical and Chemical Industry, including positions reporting directly to the Head of Research & Development at Bayer and Merck. Multi-year member in the drug discovery research review boards of Merck and Bayer Convincing track record in R&D management, innovation management and drug discovery Appointed in 2021 by the President of the Federal Republic of Germany as member of the German Council of Science and Humanities (Wissenschaftsrat) Member of the LOEWE Scientific Advisory Board Hessen Member of the Executive Board BioRN Network e.V. Member of the Board of Directors SGC Structural Genomics Consortium http://www.ulrichbetz.de Twitter: @UlrichBetz >90 publications & patents (Cell (2x), Cell Reports, Nature Medicine, Nature Biotechnology, Nature Reviews Chemistry) Author of the book ''Curious 2018 - Future Insights in Science and Technology'', Springer Multiple Awards: International Business Awards - Stevie Gold Award 2018 - Manager of the year pharmaceuticals International Business Awards - Stevie Gold Award 2018 - Innovator of the year Edison Award 2017 German Gold Stevie Award Manager of the year 2017 German Industry Innovation Award 2015 German Idea Award 2014 BioIT World Best Practice Award 2012 Scholarship of the German National Academic Foundation Leader of the science & technology work stream for Merck's 350th anniversary in 2018. Designed and managed Curious2018 - Future Insight conference (http://curious2018.com) and Future Insight Prize Enabled dozens of innovation projects for new products with business potential of several hundred million euros in an innovation incubator at Merck Designed and implemented new ''outcubation'' open innovation approach and published in Nature Biotechnology Inventor and manager of the Merck Innovation Cup (http://innovationcup.merckgroup.com) Designed and rolled-out company wide innovation initiative innospire for global idea sourcing and enablement in an entrepreneurial setting, with direct sponsorship from the Merck board Post merger integration after acquisition of Serono and Millipore by Merck Designer and manager of innovation incubator innospire that led to multiple new products. Co-inventor of HCMV inhibitor Letermovir (Prevymis) which has successfully been approved by the FDA. Co-inventor of HSV inhibitor Pritelivir which has successfully passed phase II clinical trials. Dr. rer. nat. (''mit Auszeichnung'') Dipl. Biochem. (''sehr gut'') Abitur ''1.1''